732
LESNIEWSKA ET AL.
acetate [26] in acidic conditions assumes the involve-
ment of two water molecules and the formation of a
tetrahedral intermediate. The protonation of carbonyl
oxygen facilitates the addition of one water molecule
at the carbonyl carbon to form a tetrahedral intermedi-
ate, which is stabilized by an additional water molecule
via a hydrogen bond [26]. In this case, the hydrolysis
proceeds in two steps, i.e. the formation of the tetra-
hedral intermediate and its decomposition. A similar
two-step mechanism was proposed for acidic hydrol-
ysis of ethyl acetate and ethyl benzoate studied by a
model cluster consisting of an ester, a H3O+ cation
and 15 water molecules [27]. However, in case of three
explicit water molecules included in the modeled reac-
tion, the hydrolysis proceeds in one step and the tetra-
hedral intermediate does not form in the acid-catalyzed
hydrolysis of ethyl benzoate [28]. Calculated values
of activation energy (ꢀE‡) of the hydrolysis reaction
of methyl acetate, ethyl acetate, and ethyl benzoate
in the proposed models of reaction were 18.3 [26],
19.18 [27], and 25.10 kcal mol−1 [27], respectively.
It is common knowledge that the rates of chemical
reactions are dependent on their activation energies.
The values of the catalytic rate constants of the hy-
drolysis of ACV esters in the present experiments are
approximately two (iBut-), 10 (Piv-), and 100 times
(Etc-, Nic-) lower than the value determined for acetate
ACV (Table IV), which indicates differences in the ac-
tivation energies of their acid hydrolysis. Therefore, in
accordance with [26,27], the stability of these esters is
due to differences in activation energy of the reaction.
This may provide an additional explanation for such a
high stability of nicotinoyl and ethoxycarbonyl esters.
In case of the ethoxycarbonyl ester (carbonate es-
ter), its stability should be explained by the difference
in the mechanism of the reaction in comparison with
the other esters (Scheme 1). That fact may result from
the two-step reaction in which an unstable intermedi-
ate product has been formed. The intermediate peak
was not observed as an additional peak in the chro-
matogram of HPLC, and therefore the kinetic param-
eters of the reaction of its formation and hydrolysis
were not determined. This is a two-step reaction, and
its rate is determined by the first stage of the hydrol-
ysis, which is slower than the second stage. A rapid
preequilibrium protonation step is followed by a slow
bimolecular reaction, the attack of a water molecule
and carbonyl-oxygen fission [29–31]. Subsequently,
the reaction is followed by a fast unimolecular acyl-
oxygen fission of the alkyl hydrogen carbonate [30,32].
The stability studies of the phenolic carbonate esters
demonstrated that the carbonate esters appear to be
less reactive than the corresponding carboxylic acid
ester derivatives [33]. Thus, the mechanism of the
hydrolysis reaction of the Etc-ACV reaction (Scheme
1b) is compliant with the mechanism proposed by
Østergaard and Larsen [33].
CONCLUSIONS
The validated RP-HPLC methods have been developed
for stability studies of ACV esters (Ac-, iBut-, Piv-,
Etc-, Nic-) in acidic medium. The methods are precise,
accurate, linear and simple for this purpose. The devel-
oped chromatographic parameters allow the determi-
nation of ACV esters in the mixture with degradation
products. In the acidic medium (pH 0.42–1.38) at tem-
perature 310 K, the hydrolysis of the protonated form
by hydrogen ions and spontaneous hydrolysis of the
protonated form by water were observed. The stabil-
ity of the ACV esters is determined not only by steric
properties of their chemical structure. The hydrolysis
of the ethoxycarbonyl ester of ACV (Etc-ACV) is a
two-step reaction.
This study was partly supported by the UMP grant
no 502–14–03305411–99674 and 502–01–03319427–
08870.
BIBLIOGRAPHY
1. Dziecia˛tkowski, T.; Rola, A.; Majewska, A.; Solarska,
M.; Łuczak, M. Adv Microb 2007, 46, 211–221.
2. Baele, J. M.; Block, J. H. Wilson and Gisvold’s Textbook
of Organic Medicinal and Pharmaceutical Chemistry,
12th ed.; Wolters Kluwer Health; Lippincott Williams
& Wilkins: Philadelphia, PA, 2011; pp. 341.
3. Zaja˛c, M.; Pawełczyk, E.; Jelin´ska, A. Pharmaceutical
Chemistry for Students and Pharmacists; Wydawnictwo
Naukowe Akademii Medycznej: Poznan, Poland, 2006;
pp. 530–533 (in Polish).
4. Zhang, J. H.; Zhu, J. B.; Chen, X. J.; Zhao, R.; Gang,
Y. Y.; Wu, Z. H.; Cheng, K.; Xu, X. Y. Eur J Drug Metab
Pharmacokinet 2001, 26, 145–148.
5. Yang, Q.; Hu, Q. Eur J Drug Metab Pharmacokinet 2006,
31, 17–20.
6. Tao, Y.; Lu, Y.; Sun, Y.; Gu, B.; Lu, W. ; Pan, J. Int J
Pharm 2009, 378, 30–36.
7. Caldero´n, L.; Harris, R.; Cordoba-Diaz, M.; Elorza, M.;
Elorza, B.; Lenoir, J.; Adriaens, E.; Remon, J. P.; Heras,
A.; Cordoba-Diaz, D. Eur J Pharm Sci 2012, 48, 216–
222.
8. Beutner, K. R. Antiviral Res 1995, 28, 281–290.
9. Smith, J. P.; Weller, S.; Johnson, B.; Nicotera, J.; Luther,
J. M.; Haas, D. W. Antimicrob Agents Chemother 2010,
54, 1146–1151.
10. Granero, G. E.; Amidon, G. L. Int J Pharm 2006, 317,
14–18.
11. Katragadda, S.; Jain, R.; Kwatra, D.; Hariharan, S.;
Mitra, A. K. Int J Pharm 2008, 362, 93–101.
International Journal of Chemical Kinetics DOI 10.1002/kin.20943